Pharmaceutical & Healthcare

Reduce risk, improve asset performance and increase return on investment

For pharmaceutical and healthcare companies needing to manage:

• The unprecedented demand for affordable drugs and healthcare
• The effects of global population growth
• Diseases and health concerns in both the developing and developed world

Pharmaceutical sector capital assets

Take into account that pharmaceutical assets are:

• Highly technical and specialised, often incorporating intellectual property
• Complex assets with polarised residual market values
• Material balance sheet assets

Healthcare sector capital assets

A significant number and value of assets, from laboratory estate to clinical equipment

• Global markets with predictable residual values
• Utilised by public and private sector organisations

Why sector expertise matters in the pharmaceutical and healthcare sector

Hickman Shearer’s experts understand the capital asset challenges associated with:

• Stringent contamination regulations
• Significant R&D cost management
• A complex global production supply chain
• Retaining accurate fixed asset records and information
• Using book values to benchmark transactions

A comprehensive range of sector specific services including:

• Valuation for financial reporting, loan collateral, restructuring, expert witness or insurance
• Capital asset management to verify and improve asset performance
• Used equipment sales to release funds to achieve strategic goals